Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GERN - 3 Things In Biotech June 11: Acceleron's Second Punch Advaxis's Letdown Seattle's New Hope

GERN - 3 Things In Biotech June 11: Acceleron's Second Punch Advaxis's Letdown Seattle's New Hope

Geron Corporation

Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.

Acceleron and Celgene land another big blow with their TGF blocker

Company: Acceleron (XLRN) and Celgene (CELG)

Therapy: Lustpatercept

Disease: Beta-thalassemia

News: Following on recent news that lustpatercept improved survival in patients with lower-risk myelodysplastic syndrome, XLRN and CELG have announced that the BELIEVE study also met its primary study endpoint of erythroid response, defined as a reduction of transfusion

Read more ...
Stock Information
Company Name: Geron Corporation
Stock Symbol: GERN
Market: NASDAQ
Website: geron.com
Menu
GERN GERN Quote GERN Short GERN News GERN Articles GERN Message Board
Get GERN Alerts

News, Short Squeeze, Breakout and More Instantly...